Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4216933
Max Phase: Preclinical
Molecular Formula: C44H67N9O6
Molecular Weight: 818.08
Molecule Type: Small molecule
Associated Items:
ID: ALA4216933
Max Phase: Preclinical
Molecular Formula: C44H67N9O6
Molecular Weight: 818.08
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1cc(-c2ccccc2)nc1[C@@H]1CCCN1C(=O)[C@H](CC1CCCC1)NC(=O)[C@H](CN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(C)=O)C(C)C
Standard InChI: InChI=1S/C44H67N9O6/c1-7-51-26-35(31-17-9-8-10-18-31)47-39(51)36-19-13-21-52(36)44(59)33(24-30-15-11-12-16-30)48-40(55)34(25-45)49-42(57)38(28(4)5)50-41(56)37-20-14-22-53(37)43(58)32(23-27(2)3)46-29(6)54/h8-10,17-18,26-28,30,32-34,36-38H,7,11-16,19-25,45H2,1-6H3,(H,46,54)(H,48,55)(H,49,57)(H,50,56)/t32-,33-,34-,36-,37-,38-/m0/s1
Standard InChI Key: WPGWVGAREBBLSP-ABSZIYDWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 818.08 | Molecular Weight (Monoisotopic): 817.5214 | AlogP: 3.42 | #Rotatable Bonds: 18 |
Polar Surface Area: 200.86 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.83 | CX Basic pKa: 8.09 | CX LogP: 2.58 | CX LogD: 1.82 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.15 | Np Likeness Score: -0.38 |
1. Du L, Grigsby SM, Yao A, Chang Y, Johnson G, Sun H, Nikolovska-Coleska Z.. (2018) Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL., 9 (9): [PMID:30258537] [10.1021/acsmedchemlett.8b00175] |
Source(1):